Lv5
1494 积分 2020-09-19 加入
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma
1天前
已完结
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
3天前
已完结
PAPOLA-mediated hyperactive polyadenylation promotes leukemogenesis and leukemia stem cell self-renewal through metabolic reprogramming
3天前
已完结
[Expert consensus on the management practice of CD19 CAR-T cell therapy for B-cell lymphoma in China (2025 edition)]
4天前
已完结
A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma
6天前
已完结
Single-cell and longitudinal transcriptomics-guided engineering of FZD1-targeting precision nanotherapy against osteosarcoma cancer stem cells
12天前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
13天前
已完结
Immunoferroptosis: ferroptosis meets tumor immunity and immunotherapy
13天前
已完结
Aspirin induces glycolytic reprogramming via lysine salicylation of ALDOA
14天前
已完结
Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion
14天前
已完结
皖公网安备34019202002308
